P2Y12 inhibitor intensity de-escalation in patients with acute coronary syndromes
Eur Heart J
.
2023 Apr 17;44(15):1371-1373.
doi: 10.1093/eurheartj/ehad050.
Authors
Gjin Ndrepepa
1
,
Adnan Kastrati
1
2
Affiliations
1
Klinik für Herz und Kreislauferkrankungen, Deutsches Herzzentrum München, Technische Universität München, Munich, Germany.
2
DZHK (German Center for Cardiovascular Research), partner site Munich Heart Alliance, Lazarettstraße 36, D-80636, Munich, Germany.
PMID:
36883324
DOI:
10.1093/eurheartj/ehad050
No abstract available
Publication types
Editorial
Comment
MeSH terms
Acute Coronary Syndrome* / drug therapy
Clopidogrel / therapeutic use
Dual Anti-Platelet Therapy
Humans
Platelet Aggregation Inhibitors* / adverse effects
Substances
Platelet Aggregation Inhibitors
Clopidogrel